<?xml version="1.0" encoding="UTF-8"?>
<ref id="B117-molecules-25-01015">
 <label>117.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Maga</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Falchi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Garbelli</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Belfiore</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Witvrouw</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Manetti</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Botta</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3</article-title>
  <source>J. Med. Chem.</source>
  <year>2008</year>
  <volume>51</volume>
  <fpage>6635</fpage>
  <lpage>6638</lpage>
  <pub-id pub-id-type="doi">10.1021/jm8008844</pub-id>
  <pub-id pub-id-type="pmid">18834110</pub-id>
 </element-citation>
</ref>
